Skip to content
Surprising Science

Fighting Fat

A new anti-obesity drug has proved successful in trials with fewer side effects than traditional treatments. But could cost limit its use?
Sign up for Smart Faster newsletter
The most counterintuitive, surprising, and impactful new stories delivered to your inbox every Thursday.

“People taking the highest dose of a new anti-obesity drug lost more than a stone in weight in 20 weeks,” reports The Independent. “The amount of weight lost was almost three times that in a control group given a placebo and 50 per cent more than those given a rival treatment, which is the current brand leader for the treatment of obesity. The drug, liraglutide, is the first of a new class of anti-obesity agents which mimic the action of a hormone that occurs naturally in the gut, reducing hunger. Experts said it had ‘great potential’ because it also reduced the risk factors for Type 2 diabetes and heart disease…But they warned that the high cost of the drug – around £500 [in the UK where its being tested] for six months’ supply at the lowest dose – could limit its use.”

Sign up for Smart Faster newsletter
The most counterintuitive, surprising, and impactful new stories delivered to your inbox every Thursday.

Related

Up Next